In gliomas, the HSP90B1 overexpression was also associated with the increased tumor aggressiveness and the worsening of clinical outcomes[31], implying a role for HSP90B1 in the development of GBMs. The gene discussed is HSP90B1; the disease is central nervous system cancer.